Neoleukin Therapeutics, Inc. held its 2023 Annual Meeting of Stockholders, where various matters were presented and voted upon, including the election of directors, approval for a reverse stock split, amendment to permit exculpation of officers, ratification of the appointment of an accounting firm, and approval of executive compensation.